Pricing with confidence in a fear-driven market with Scott Leick, RhythmScience

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/b1/e1/c4/b1e1c4e5-7052-60a6-9a0c-260e4458562d/mza_4593908185100969961.jpg/600x600bb.jpg

If Prices Could Talk

Holden Advisors

44 episodes

4 days ago

Welcome to If Prices Could Talk, the podcast where we explore the strategies and tactics that drive effective pricing, sales, and negotiations in B2B. Join us for candid conversations with thought leaders and industry experts as we dive into what’s working, what’s changing, and how to build and sustain pricing power in today’s markets. We’ll explore tactical approaches to value-based pricing, improving sales effectiveness, and best practices for negotiating with backbone.

Business

RSS

All content for If Prices Could Talk is the property of Holden Advisors and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42569064/42569064-1733085062089-024cd265900bb.jpg

Pricing with confidence in a fear-driven market with Scott Leick, RhythmScience

If Prices Could Talk

53 minutes 16 seconds

6 months ago

Pricing with confidence in a fear-driven market with Scott Leick, RhythmScience

In this episode, Tracy sits down with Scott Leick, SVP of Finance & Analytics at RhythmScience, and Patrick McCullough, Partner at Holden Advisors, to discuss pricing, analytics, negotiations, and new product launches.

We discuss:

How to use analytics to replace gut instinct in pricing decisions
Lessons from the drug-eluting stent “race to the bottom” on price
How to price new tech when the market is uncertain
The impact of private equity ownership on purchasing power
How to align commercial teams when sellers are under pressure to deliver

About Scott

Scott Leick is the SVP of Finance and Marketing at RhythmScience. He has almost 25 years of experience in pricing at companies from the Fortune 50 to Series A SaaS startups, including executive roles at Medtronic, C.H. Robinson, and Acutus Medical.

Learn more about RhythmScience: https://www.rhythm360.io

Learn more about Holden Advisors: https://www.holdenadvisors.com

Connect with Scott: https://www.linkedin.com/in/scottwleick/

Connect with Patrick: https://www.linkedin.com/in/pmccullough-holdenadvisors/

Connect with Tracy: https://www.linkedin.com/in/tracyleighdent/

CHAPTERS

00:00 Introductions

04:01 How data builds sales confidence in B2B

17:26 Lessons from price wars

27:55 How to price new tech without undervaluing innovation

35:16 Pricing discipline when sales pushes for volume

37:36 How PE ownership is reshaping purchasing power

51:10 Advice for navigating pricing pressure and defending value